Cargando…
Treatment of Glucocorticoid-Induced Osteoporosis and Risk Factors for New Vertebral Fractures in Female Patients with Autoimmune Diseases
We aimed to evaluate the compliance of physicians with the 2014 guidelines of the Japanese Society for Bone and Mineral Research, for the prevention and treatment of glucocorticoid (GC) induced osteoporosis (GIO) and to investigate the risk of fracture and other associated risk factors in bisphospho...
Autores principales: | Shinoda, Koichiro, Taki, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560280/ https://www.ncbi.nlm.nih.gov/pubmed/34733465 http://dx.doi.org/10.1155/2021/5515653 |
Ejemplares similares
-
Evaluation of risk factors of vertebral fracture in Japanese female patients with glucocorticoid-induced osteoporosis
por: Mori, Yu, et al.
Publicado: (2020) -
Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses
por: Florez, Helena, et al.
Publicado: (2020) -
Potential underdiagnosis of osteoporosis in repeated vertebral augmentation for new vertebral compression fractures
por: İlhan, Birkan, et al.
Publicado: (2015) -
Glucocorticoid-induced osteoporosis
por: Briot, Karine, et al.
Publicado: (2015) -
Glucocorticoid-induced Osteoporosis
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2017)